DNA CRUCIFORMS AND HUMAN DISEASE
DNA CRUCIFORMS AND HUMAN DISEASE
批准号:
2414729
负责人:
JOHN J BISSLER
金额:
$7.67万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-05-01 至 2000-04-30
关键词:
CD40 molecule DNA DNA damage DNA replication Escherichia coli antithrombins chemical stability gene mutation genetic disorder human genetic material tag human immunodeficiency virus molecular cloning molecular pathology nucleic acid repetitive sequence nucleic acid sequence nucleic acid structure plasmids platelet derived growth factor polymerase chain reaction polymerization recombinant DNA transfection /expression vector
中文摘要
作为宝洁公司的一名学者,比斯勒博士发现了C1抑制剂的突变
遗传性血管神经性水肿40个家系的(C1INH)基因他发现
两个似乎共享固有DNA复制的突变热点
不忠。作为他研究的一部分,他将研究突变热点
这里概述的是C1INH基因的外显子8。这一地区形成了一个
热力学稳定的阀杆环结构。发现了相似的结构
在抗凝血酶III(ATIII)人类免疫缺陷病毒TAR和
血小板驱动生长因子A基因。ATIII和C1INH也是集群
参与这些十字形结构的序列中的点突变。
他将研究这些基因形成十字形结构和
研究这些十字架对真核生物复制机制的影响。
目前,研究内在突变机制的方法是人工的。
密集的需要广泛的序列分析。比斯勒博士设计了
一种有可能选择性地只分离细菌的系统
含有发生了移码或移位的突变质粒的
诱变。这种方法将大大减少访问所需的劳动力
各种人类疾病的十字形细胞的假定致突变性
相关基因。通过组合来自突变的信息
频率和真核复制机制暂停,比斯勒博士将
更清楚地定义复制暂停在突变中的作用。更好
对涉及内在DNA不稳定性的因素的理解是
对阐明诱变的基本机制具有重要意义。这个
来自拟议研究的观察结果将直接影响到
可能用于基因治疗的稳定结构。
比斯勒博士目前的环境非常适合支持他的
持续的职业发展。他有了自己的办公室,
实验室空间。实验室里有他需要的设备。
学习,他可以使用儿童医院的核心设备
研究基金会,包括最先进的寡核苷酸合成
设施。比斯勒博士将得到这项研究的财政支持
基金会将前往休斯顿,以便向Dr。
辛登,一名顾问。比斯勒博士的毒蛇凯瑟琳·迪克森博士
在帮助年轻调查人员培养独立能力方面有丰富的经验
从事实验室调查工作,并在多个领域拥有科学专长
比斯勒博士打算研究的。比斯勒博士也将有足够的
通过参加以下活动来加深他的基础科学知识
杂志俱乐部、研讨会和课程。
英文摘要
As a Procter Scholar, Dr. Bissler identified mutations in the C1 inhibitor
(C1INH) gene from 40 kindred with hereditary angioneurotic edema. He found
two mutation hotspots which appear to share intrinsic DNA replication
infidelity. The mutation hotspot he will investigate as part of his studies
outlined here is in exon 8 of the C1INH gene. This region forms a
thermodynamically stable stem loop structure. Similar structures are found
in the Antithrombin III (ATIII) human immunodeficiency virus TAR and
platelet drive growth factor A genes. Both ATIII and C1INH also cluster
point mutations in the sequence which engages in these cruciform structues.
He will study the ability of these genes to form cruciform structures and
examine the effect of these cruciforms on eukaryotic replication machinery.
Currently, the methods for studying intrinsic mutation mechanisms are labor
intensive requiring extensive sequence analysis. Dr. Bissler has designed
a system which has the potential to selectively isolate only bacteria
harboring mutant plasmid which has undergone frameshift or point
mutagenesis. This method will greatly reduce the labor required to access
the putative mutagenicity of the cruciform from various human disease
associated genes. By combining the information from the mutation
frequencies and eukaryotic replication machinery pausing, Dr. Bissler will
more clearly define the role of replication pausing in mutagenesis. Better
understanding of the factors involved in intrinsic DNA instability is
important to elucidate the basic mechanisms of mutagenesis. The
observations from the proposed research will bear directly on the creation
of stable constructs which might be used for gene therapy.
Dr. Bissler's current environment is uniquely suited to support his
continued career development. He has been provided with his own office and
laboratory space. The laboratory contains the equipment needed for his
studies, and he has access to core equipment at the Children's Hospital
Research Foundation, includes state of the art oligonucleotide synthesis
facilities. Dr. Bissler will be financially supported by the Research
Foundation to travel to Houston in order to learn techniques from Dr.
Sinden, a consultant. Dr. Bissler's snsor, Dr. Kathieen Dixon, has had
extensive experience in assisting young investigators develop independent
careers in laboratory investigation and has scientific expertise in areas
that Dr. Bissler proposes to study. Dr. Bissler also will have ample
opportunity to further his basic science knowledge by participating in
journal clubs, seminars and classes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RAPAMYCIN THERAPY OF RENAL ANGIOMYOLIPOMAS
-
批准号:7607742
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2007
-
负责人:JOHN J BISSLER
-
依托单位:
RAD001 THERAPY OF ANGIOMYOLIPOMATA IN PATIENTS WITH TSC
-
批准号:7607778
-
项目类别:
-
资助金额:$1.89万
-
财政年份:2007
-
负责人:JOHN J BISSLER
-
依托单位:
RAPAMYCIN THERAPY OF RENAL ANGIOMYOLIPOMAS
-
批准号:7374516
-
项目类别:
-
资助金额:$3.9万
-
财政年份:2005
-
负责人:JOHN J BISSLER
-
依托单位:
RAD001 THERAPY OF ANGIOMYOLIPOMATA IN PATIENTS WITH TSC
-
批准号:7374557
-
项目类别:
-
资助金额:$0.53万
-
财政年份:2005
-
负责人:JOHN J BISSLER
-
依托单位:
RAPAMYCIN THERAPY OF RENAL ANGIOMYOLIPOMAS
-
批准号:7203768
-
项目类别:
-
资助金额:$4.98万
-
财政年份:2004
-
负责人:JOHN J BISSLER
-
依托单位:
DNA Replication Fork: Pausing, Recombination and Disease
-
批准号:6740173
-
项目类别:
-
资助金额:$22.45万
-
财政年份:2003
-
负责人:JOHN J BISSLER
-
依托单位:
Rapamycin Therapy of Renal Angiomyolipomas
-
批准号:7044210
-
项目类别:
-
资助金额:$1.64万
-
财政年份:2003
-
负责人:JOHN J BISSLER
-
依托单位:
DNA Replication Fork: Pausing, Recombination and Disease
-
批准号:6859415
-
项目类别:
-
资助金额:$22.21万
-
财政年份:2003
-
负责人:JOHN J BISSLER
-
依托单位:
DNA Replication Fork: Pausing, Recombination and Disease
-
批准号:7194967
-
项目类别:
-
资助金额:$20.58万
-
财政年份:2003
-
负责人:JOHN J BISSLER
-
依托单位:
Utility of Rapamycin for the Treatment of Renal Angiomy*
-
批准号:6795885
-
项目类别:
-
资助金额:$27.43万
-
财政年份:2003
-
负责人:JOHN J BISSLER
-
依托单位:
DNA Replication Fork: Pausing, Recombination and Disease
-
批准号:7030211
-
项目类别:
-
资助金额:$21.44万
-
财政年份:2003
-
负责人:JOHN J BISSLER
-
依托单位:
DNA Replication Fork: Pausing, Recombination and Disease
-
批准号:6576325
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2003
-
负责人:JOHN J BISSLER
-
依托单位:
Rapamycin for the Treatment of Renal Angiomyolipomas
-
批准号:6695424
-
项目类别:
-
资助金额:$27.43万
-
财政年份:2003
-
负责人:JOHN J BISSLER
-
依托单位:
DNA CRUCIFORMS AND HUMAN DISEASE
-
批准号:2701038
-
项目类别:
-
资助金额:$9.5万
-
财政年份:1998
-
负责人:JOHN J BISSLER
-
依托单位:
DNA CRUCIFORMS AND HUMAN DISEASE
-
批准号:2134365
-
项目类别:
-
资助金额:$7.67万
-
财政年份:1996
-
负责人:JOHN J BISSLER
-
依托单位:
DNA CRUCIFORMS AND HUMAN DISEASE
-
批准号:2904945
-
项目类别:
-
资助金额:$10.8万
-
财政年份:1996
-
负责人:JOHN J BISSLER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PCV2茎环结构DNA激活cGAS-STING通路诱导的天然免疫应答的作用研究
-
批准号:2026JJ50413
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王东亮
-
依托单位:
机械力响应型DNA探针用于肿瘤微环境细胞力学可视化与药物筛选研究
-
批准号:2026JJ60135
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨思慧
-
依托单位:
CDC45通过调控DNA复制应激促进肝癌发生发展的机制
-
批准号:2026JJ82714
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵志坚
-
依托单位:
自供能传感阵列同步量化游离DNA与PSA实现前列腺癌的诊断和预后判断
-
批准号:JCZRLH202601177
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
二氢杨梅素通过线粒体代谢重编程抑制DNA同源重组修复逆转口腔癌细胞放疗抵抗的机制研究
-
批准号:2026JJ80500
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:阳帆
-
依托单位:
乳酸通过ESM1-Akt-MDM2-p53通路调控卵巢癌DNA损伤和抗肿瘤免疫应答的分子机制研究
-
批准号:2026JJ81975
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖娇
-
依托单位:
淫羊藿苷通过TET2介导DNA去甲基化调控Hippo-YAP/TAZ通路逆转绝经后骨质疏松症成血管-成骨耦联失衡的机制研究
-
批准号:2026JJ82371
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王哲享
-
依托单位:
基于孕妇外周血游离DNA靶向捕获测序筛查胎儿隐性单基因病的探索研究
-
批准号:JCZRLH202600067
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
WSTF/SNF2H 介导的 DNA 损伤在 DPSCs 衰老中的机制研究
-
批准号:ZCLQN26H1401
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:虞其豪
-
依托单位:
孕期多环芳烃暴露与DNA甲基化改变对子代神经发育影响的出生队列研究
-
批准号:2026JJ81844
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吕玲双
-
依托单位: